Creator Post Archive
Martin Shkreli
Browse the full post archive, then jump into the source post to inspect linked mentions and linked signals.
Jul 1, 2026
7/1/26 -2.1%
Martin Shkreli discusses Meta's potential move into cloud services, initially expressing concern that it could reduce demand for component makers like Nvidia. However, he later revises his view, suggesting that if Meta is offering compute power alongside their models, it could be bullish. He also briefly mentions Neuralink and Amazon.
Jun 30, 2026
6/30/26 +0.93%
The creator discusses various topics including technology, the human spirit, and personal hustle. He mentions Nvidia as a hardware company and highlights Asana Sciences as a generational opportunity. A significant portion of the content is dedicated to a critique of the FDA's stance on BPC 157, a peptide, arguing against its approval due to lack of evidence and questionable research origins.
Jun 29, 2026
6/29/26 +0.25%
Martin Shkreli discusses Nvidia's position as a hardware company, a potential generational opportunity in a small biotech, and the upcoming adcom for Capricorn. He also touches on Micron's stock movement due to memory news, Intel's entry into the memory market, Comcast spinning off NBC Universal, and Rocket Lab's acquisition of Idium, expressing a desire to short Rocket Lab based on the acquisition headline.
Jun 26, 2026
6/26/26 -0.80%
The creator discusses several stocks, including Micron, expressing a bullish sentiment on its memory cycle and revenue growth, noting its significant investment in property, plant, and equipment. He also touches on other companies like Aadia, Emix Bioarm, and Capricorn, with mixed or unresolved sentiments.
May 4, 2026
5/4/26 - we're back until 11am
Martin Shkreli discusses the nature of companies like Nvidia, contrasting hardware and software, and expresses strong interest in Casada Sciences, a small biotech company he views as a generational opportunity. He also comments on the significant drop in Xanadoo's stock price following a lock-up expiry, attributing it to early shareholders selling their shares.
Apr 6, 2026
4/6/26 - sorry for the wait!
Martin Shkreli returns after an illness, discussing various topics including biotech deals, drug development, and personal health regimens. He touches on Seleno acquisition by Nurocran, Lightwave Logic, Amgen's execution, and mentions Biogen and Viatris with some commentary.
Mar 20, 2026
3/20/26 - sorry for the wait!
The creator discusses several companies including Super Micro, Planet Labs, Moderna, Denali, and Arrowhead. He expresses surprise at Super Micro's stock drop, notes Planet Labs' record revenue, and highlights Arrowhead as a significant past winner and Surreptit's partner.
Feb 25, 2026
2/25/26 - NVDA earnings release
Dry-run Step 5 insert for NVDA
Dec 5, 2025
12/4/25 challenge account -100% RIP - QCLS is the new thing
Martin Shkreli discusses the failure of his challenge account, attributing it to a bad pick in Capra. He expresses renewed interest in QCLS, a company focused on photonic computing, which he believes is superior to quantum computing. Shkreli plans to take a job at QCLS and will shift his focus from trading to analyzing stocks for his community.
Dec 3, 2025
12/3/25 CAPR WATCH
The creator is highly skeptical of Capricorn Therapeutics' (CAPR) reported topline data for the hope three trial, alleging the company has changed its primary endpoint and is misrepresenting the results. He believes the reported changes are statistically insignificant and indicative of past "shenanigans" that led to approval failures.
Dec 2, 2025
12/2/25 +479% CAPR WATCH
The creator discusses several stocks including Corvus Pharmaceuticals (CAPR), Nvidia (NVDA), Apple (AAPL), Genex (GENX), and AstraZeneca (AZN). The primary focus is on CAPR, which is awaiting significant binary event data. The creator also touches on market movements and trading commissions.
Nov 20, 2025
11/19/25 +474% part 2 - NVDA WATCH
The creator is closely watching Nvidia's upcoming earnings report, anticipating a potential "shock and awe" performance with strong revenue and guidance. While not currently holding a position, the creator expresses a long bias if forced to choose.
Nov 10, 2025
11/10/25 +536% CAPR after close!
The creator discusses several stocks including Palantir and Nvidia, noting past successful trades with call options. He expresses a short position on Capricor (CAPR), citing it as a high conviction trade despite acknowledging the company's earnings call. He also mentions being down on IHRX and generally advises against options trading for inexperienced individuals.
Sep 12, 2025
9/12/25 +59% atyr watch day 8
The creator discusses a bubble-like market environment and mentions several stocks including Yegg, Visor, and IonQ. He notes having previously shorted Visor at its peak and expresses a painful experience shorting another "cult stock". The video also touches on IonQ's investor day and its quantum leadership.
Sep 11, 2025
9/11/25 +58% atyr watch day 7
The creator discusses the stock Atyr (ATYR), noting the new CEO's importance and the potential for a turnaround. They are working on a research report for ATYR, delving into its 2014 research papers and the scientific basis for its treatments, while also mentioning UCO as a potentially interesting but uncertain business.
Sep 8, 2025
9/8/25 +56% atyr watch day 4
The creator expresses a negative view on the biotech sector, calling it a "dead sector" and a "waste of time," and suggests that investors would be better off following software instead.
Sep 8, 2025
9/8/25 +55% atyr watch day 4 PART 2
The creator discusses the biotech company Avivax, noting its current call and potential. He also reflects on Celgene's history, particularly its hit product Revlimid and its limitations. The creator mentions a potential trade on 'Octo' due to its perceived market inefficiency, drawing a parallel to a past successful trade with Espa.
Sep 8, 2025
9/8/25 +54% atyr watch day 4 PART 3
The creator discusses the stock ATYR, noting that short maintenance requirements might make options a better strategy. He expresses confidence in his position, stating "I'm short and I have puts." The creator also mentions "cassava" at the end, but without a clear directional stance.
Sep 5, 2025
9/3/25 +55% ATYR WATCH day 2
The creator discusses American Eagle Outfitters (AEO) with a 33% gain and mentions Salesforce (CRM) multiple times, suggesting an upgrade or positive outlook. There is no concrete news on ATYR yet, and the creator is hesitant to invest fully, considering shorting the stock instead. The creator also touches on AI and potential acquisitions.
Sep 5, 2025
9/5/25 +59% atyr watch day 3
The creator is discussing a stock, ATYR, and its performance, noting a significant gain. The content is repetitive and focuses on the stock's progress over several days.
Aug 28, 2025
8/27/25 +60% NVDA EPS - attempt FIVE
The creator discusses several stocks including Nvidia, Abbyax, Quantum, Newegg, Preceden, and IBVD. He highlights a successful trade in Abbyax and a short position in Newegg. He expresses skepticism towards small-cap stocks and mentions having a small position in EQ.
Aug 20, 2025
8/19/25 +56% $VKTX RIP, quantum falling
This video features an interview with Max Dama, co-chair of Headlands Technology, a quant prop trading firm. They discuss Dama's background, his early interest in AI and trading, and his experiences in the trading industry.
Aug 15, 2025
8/15/25 +46% record high! PGEN, Scorpion SLNO short
The creator discusses a short report released by Scorpion Capital targeting a biotech company, PGEN. He also mentions considering shorting Joby Aviation and briefly touches on UnitedHealth Group (UNH) and SLNO. The creator expresses uncertainty about PGEN's commercialization and potential capital raises, while finding it somewhat attractive at its current valuation.
Aug 7, 2025
8/6/25 +18% IONQ SRPT
The creator discusses earnings reports and financial metrics for several companies, expressing confusion and skepticism about some of the reported figures and guidance. There's a particular focus on revenue, RPO, and cash flow, with mentions of IonQ, SRPT, and other unnamed companies.
Aug 5, 2025
8/5/25 +21% earnings season continues
The creator provides a brief market update, mentioning several stocks and their performance. He highlights Quantum Computing Inc.'s small deal, discusses the performance of various companies like Alcon, Navatas, HIMS, Nvidia, Palantir, Tesla, and Castle Bioscience. He also touches on international stocks like GSK, Shell, Toyota, and Ubisoft.
Showing 1-25 of 31 posts · Page 1 of 2